Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
16.76
-0.36 (-2.10%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Contineum Therapeutics Statistics

Total Valuation

CTNM has a market cap or net worth of $431.12 million. The enterprise value is $213.07 million.

Market Cap 431.12M
Enterprise Value 213.07M

Important Dates

The next estimated earnings date is Saturday, November 16, 2024, before market open.

Earnings Date Nov 16, 2024
Ex-Dividend Date n/a

Share Statistics

CTNM has 25.72 million shares outstanding. The number of shares has increased by 238.72% in one year.

Shares Outstanding 25.72M
Shares Change (YoY) +238.72%
Shares Change (QoQ) +885.86%
Owned by Insiders (%) 1.54%
Owned by Institutions (%) 27.70%
Float 12.69M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.98
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 58.92, with a Debt / Equity ratio of 0.00.

Current Ratio 58.92
Quick Ratio 58.48
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -$638,742
Employee Count 31
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -279,000
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 17.80
200-Day Moving Average n/a
Relative Strength Index (RSI) 45.18
Average Volume (20 Days) 77,654

Short Selling Information

The latest short interest is 952,350, so 3.70% of the outstanding shares have been sold short.

Short Interest 952,350
Short Previous Month 926,720
Short % of Shares Out 3.70%
Short % of Float 7.51%
Short Ratio (days to cover) 20.60

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -38.62M
Pretax Income n/a
Net Income -19.80M
EBITDA -38.42M
EBIT -38.62M
Earnings Per Share (EPS) -$2.61
Full Income Statement

Balance Sheet

The company has $218.65 million in cash and $597,000 in debt, giving a net cash position of $218.06 million or $8.48 per share.

Cash & Cash Equivalents 218.65M
Total Debt 597,000
Net Cash 218.06M
Net Cash Per Share $8.48
Equity (Book Value) 217.50M
Book Value Per Share 8.46
Working Capital 216.58M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$32.56 million and capital expenditures -$597,000, giving a free cash flow of -$33.15 million.

Operating Cash Flow -32.56M
Capital Expenditures -597,000
Free Cash Flow -33.15M
FCF Per Share -$1.29
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CTNM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -238.72%
Shareholder Yield -238.72%
Earnings Yield -4.59%
FCF Yield -7.69%

Analyst Forecast

The average price target for CTNM is $29.50, which is 76.01% higher than the current price. The consensus rating is "Strong Buy".

Price Target $29.50
Price Target Difference 76.01%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CTNM has an Altman Z-Score of 63.84 and a Piotroski F-Score of 1.

Altman Z-Score 63.84
Piotroski F-Score 1